Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
783.40
-9.50 (-1.20%)
At close: Feb 10, 2026
Ambee Pharmaceuticals Market Cap
Ambee Pharmaceuticals has a market cap or net worth of 1.88 billion as of February 12, 2026. Its market cap has increased by 10.62% in one year.
Market Cap
1.88B
Enterprise Value
2.43B
Revenue
193.90M
Ranking
n/a
PE Ratio
390.04
Stock Price
783.40
Market Cap Chart
Since March 3, 2008, Ambee Pharmaceuticals's market cap has increased from 123.20M to 1.88B, an increase of 1,426.10%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.88B | 10.65% |
| Dec 30, 2025 | 1.70B | 0.87% |
| Dec 30, 2024 | 1.68B | -13.94% |
| Dec 28, 2023 | 1.96B | 58.77% |
| Dec 29, 2022 | 1.23B | 11.94% |
| Dec 30, 2021 | 1.10B | 2.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |
| Navana Pharmaceuticals | 6.50B |
| Techno Drugs | 4.18B |
| Pharma Aids | 1.84B |
| Libra Infusions | 1.60B |
| Silco Pharmaceuticals | 1.46B |
| Indo-Bangla Pharmaceuticals | 1.44B |